Richmond Pharmacology Celebrates 10 Years at the Henley Royal Regatta

Posted:
4
August 2011

Richmond Pharmacology Ltd (RPL) is proud to announce that it recently celebrated its 10th anniversary in style with a quintessentially British day on the river at this year�s Henley Royal Regatta.  

The Henley Royal Regatta has been held annually since 1839 and remains one of Britain s most prestigious sporting events, and as such was a fitting place to hold this esteemed celebration.The day started off with an official welcome by RPL s co-founder and CEO, Dr Jorg Taubel, followed by a morning presentation by guest speaker, Dr Tony Soteriou, Deputy Director, Head of NHS Research Infrastructure and Industry R&D Relations from the Department of Health, looking at new initiatives to simplify the regulatory process for clinical research conducted in the United Kingdom.

After the morning presentation guests attended the prestigious Fawley Meadows Restaurant to relax and enjoy the afternoon s festivities.

Richmond Pharmacology was co-founded in August 2001 by RPL s three Executive Directors Dr Ulrike Lorch, Dr Radivoj Arezina and Dr J rg T ubel, and first opened at the Atkinson Morely Hospital in Wimbledon.  10 years on, now based in two of the UK s largest acute NHS teaching hospitals, RPL has undergone steady expansion and has since become one of Europe s leading full-service specialist early phase CROs. The first to obtain MHRA standard and supplementary accreditation for two hospital based clinical trial units coupled with its supreme expertise gained from over 500 early phase studies carried out to date, RPL is proud to be celebrating 10 years of clinical excellence, still leading the way as the experts in the field of early phase clinical research!

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Novel rate-controlled fentanyl patch shows promise in phase I clinical trial

April 1, 2021
Our expertise in ethnic differences and access to over 12,000 first generation Japanese volunteers accelerated our ability to provide robust clinical trial data to support future applications of new chronic pain medicines to the Japanese drug market.
Read more

A new era for UK-Japanese scientific relations

March 23, 2021
Dr Taubel uses his experience of conducting more than 60 Japanese bridging studies to explain why the deal is of strategic importance to the UK and highlights the scientific requirements for conducting successful Japanese trials abroad
Read more

Richmond Pharmacology’s local MP Neil Coyle calls on the Government to evaluate the potential of using Clinical Research Organisations.

February 3, 2021
Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London
Read more